Managers / Q4 2025
KEMPNER CAPITAL MANAGEMENT INC.
CIK 0000898399 · 2201 MARKET ST. 12TH FLOOR, PO BOX 119, GALVESTON, TX, 77553 · 409.765.6671
Summary
Kempner Capital Management Inc. reported $106M in U.S.-listed holdings across 43 positions for Q4 2025.
Its largest position, MU, represents 7.6% of the portfolio.
Compared with Q3 2025, the fund opened 0 new positions and exited 5.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 69.7% · $74M
- ADR · 11.0% · $12M
- Other · 7.6% · $8M
- MLP · 5.9% · $6M
- REIT · 3.7% · $4M
- Other · 2.1% · $2M
Quarter-over-Quarter Changes full breakdown →
vs Q3 2025 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| SONSONOCO PRODUCTS CO | ADDED | +28.0K | 52.9K | +$1M | $2M |
| FMCFMC CORP | SOLD OUT | −73.3K | 0 | −$2M | $0 |
| BAXBAXTER INTL INC | SOLD OUT | −62.4K | 0 | −$1M | $0 |
| LYONDELLBASELL INDUSTRIES N | SOLD OUT | −25.7K | 0 | −$1M | $0 |
| WBDWARNER BROS DISCOVERY INC | SOLD OUT | −11.2K | 0 | −$218,000 | $0 |
| SERVICE PPTYS TR | SOLD OUT | −47.5K | 0 | −$129,000 | $0 |
| CNMDCONMED CORP | TRIMMED | −43.3K | 6.3K | −$2M | $252,000 |
| SLBSLB LIMITED | TRIMMED | −48.6K | 8.0K | −$2M | $310,000 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2025
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q4 2025 | $106M | 43 | Jan 12, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $120M | 48 | Oct 16, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | Under review | 47 | Jul 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | Under review | 49 | Apr 21, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $182M | 49 | Jan 23, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $195M | 51 | Oct 21, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $189M | 50 | Jul 19, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $184M | 51 | Apr 11, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $179M | 54 | Jan 24, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $166M | 57 | Oct 19, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $156M | 55 | Jul 18, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $171M | 56 | Apr 21, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $165M | 60 | Jan 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $151M | 61 | Oct 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $164M | 61 | Jul 19, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $183M | 57 | Apr 13, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $170M | 50 | Jan 18, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $175M | 53 | Nov 1, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $176M | 51 | Jul 23, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $174M | 48 | Apr 27, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $151M | 45 | Jan 5, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $125M | 46 | Oct 6, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $127M | 46 | Jul 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $115M | 51 | Apr 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $154M | 49 | Jan 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $147M | 48 | Oct 4, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $153M | 50 | Jul 8, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $151M | 48 | Apr 5, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $145M | 49 | Jan 9, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.